Literature DB >> 7068041

Diagnosis of oesophageal spasm by ergometrine provocation.

H A Davies, M D Kaye, J Rhodes, A M Dart, A H Henderson.   

Abstract

Oesophageal spasm may mimic the pain of myocardial ischaemia. Forty-two patients who were thought to have angina until investigations failed to show any cardiovascular abnormality, were examined for oesophageal disease. Ergometrine provocation during oesophageal manometry caused significant deterioration in oesophageal motility, associated with familiar pain, in 24 patients. Ten age-matched controls were examined in a similar way and ergometrine produced motility changes in four and pain in two. Six volunteers with coronary artery stenosis and exercise-induced angina did not develop oesophageal motility changes during the pain. Ergometrine provocation is useful in establishing the diagnosis of oesophageal spasm in patients with recurrent angina-like pain but no cardiac abnormality.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068041      PMCID: PMC1419545          DOI: 10.1136/gut.23.2.89

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Improved infusion system for intraluminal esophageal manometry.

Authors:  R C Arndorfer; J J Stef; W J Dodds; J H Linehan; W J Hogan
Journal:  Gastroenterology       Date:  1977-07       Impact factor: 22.682

2.  The differentiation between oesophageal and cardiac pain.

Authors:  J R Bennett; M Atkinson
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

3.  Diaphragmatic hiatal hernia and angina pectoris.

Authors:  J E Delmonico; A Black; G G Gensini
Journal:  Dis Chest       Date:  1968-03

4.  Esophageal manometrics in patients with angina-like chest pain.

Authors:  D L Brand; D Martin; C E Pope
Journal:  Am J Dig Dis       Date:  1977-04

5.  Provocative testing for coronary arterial spasm: risk, method and rationale.

Authors:  F A Heupler
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

6.  The effects of pentagastrin in achalasia and diffuse esophageal spasm.

Authors:  R C Orlando; E M Bozymski
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

7.  Ergonovine testing in a coronary care unit.

Authors:  D D Waters; P Theroux; J Szlachcic; F Dauwe; J Crittin; R Bonan; H F Mizgala
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

8.  Oesophageal spasm and angina: diagnostic value of ergometrine (ergonovine) provocation.

Authors:  A M Dart; H A Davies; R H Lowndes; J Dalal; M Ruttley; A H Henderson
Journal:  Eur Heart J       Date:  1980-04       Impact factor: 29.983

9.  Unexplained chest pain in patients with normal coronary arteriograms: a follow-up study of functional status.

Authors:  I S Ockene; M J Shay; J S Alpert; B H Weiner; J E Dalen
Journal:  N Engl J Med       Date:  1980-11-27       Impact factor: 91.245

10.  Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin.

Authors:  A Buxton; S Goldberg; J W Hirshfeld; J Wilson; T Mann; D O Williams; P Overlie; P Oliva
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

View more
  23 in total

1.  Esophageal clearance scintigraphy, in diabetic patients--a preliminary study.

Authors:  B Karayalcin; U Karayalcin; T Aburano; K Nakajima; K Hisada; T Morise; T Okada; R Takeda
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

2.  Systematic comparison of conventional oesophageal manometry with oesophageal motility while eating bread.

Authors:  P J Howard; L Maher; A Pryde; R C Heading
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

3.  Oesophageal chest pain.

Authors:  H A Davies; A M Dart; J Rhodes; A H Henderson
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

4.  Diffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractions.

Authors:  C B Dalton; D O Castell; E G Hewson; W C Wu; J E Richter
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

5.  Manometric diagnosis of diffuse esophageal spasm.

Authors:  M L Allen; A J DiMarino
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

6.  The Research Diagnostic Criteria for Temporomandibular Disorders. V: methods used to establish and validate revised Axis I diagnostic algorithms.

Authors:  Eric L Schiffman; Richard Ohrbach; Edmond L Truelove; Feng Tai; Gary C Anderson; Wei Pan; Yoly M Gonzalez; Mike T John; Earl Sommers; Thomas List; Ana M Velly; Wenjun Kang; John O Look
Journal:  J Orofac Pain       Date:  2010

7.  Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†.

Authors:  Eric Schiffman; Richard Ohrbach; Edmond Truelove; John Look; Gary Anderson; Jean-Paul Goulet; Thomas List; Peter Svensson; Yoly Gonzalez; Frank Lobbezoo; Ambra Michelotti; Sharon L Brooks; Werner Ceusters; Mark Drangsholt; Dominik Ettlin; Charly Gaul; Louis J Goldberg; Jennifer A Haythornthwaite; Lars Hollender; Rigmor Jensen; Mike T John; Antoon De Laat; Reny de Leeuw; William Maixner; Marylee van der Meulen; Greg M Murray; Donald R Nixdorf; Sandro Palla; Arne Petersson; Paul Pionchon; Barry Smith; Corine M Visscher; Joanna Zakrzewska; Samuel F Dworkin
Journal:  J Oral Facial Pain Headache       Date:  2014

8.  Clinical value of radionuclide oesophageal transit measurement.

Authors:  J S de Caestecker; J N Blackwell; R D Adam; W J Hannan; J Brown; R C Heading
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

9.  Ergonovine-provoked esophageal spasm during coronary angiography.

Authors:  D A Lieberman; J W Jendrzejewski; J H McAnulty
Journal:  West J Med       Date:  1984-03

10.  Esophageal chest pain. Value of high-dose provocative testing with edrophonium chloride in patients with normal esophageal manometries.

Authors:  C A Lee; J C Reynolds; A Ouyang; L Baker; S Cohen
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.